Related Experiment Video
Updated: Jul 15, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity Remission: A Missing Target in Contemporary Medicine
Theocharis Koufakis1, Alexander Kokkinos2, Luca Busetto3
1Second Propaedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.
Summary
This study proposes a new remission-oriented approach for obesity management, shifting from merely slowing progression to achieving sustained remission. This framework aims for better outcomes and reduced healthcare burden by prioritizing early, effective interventions.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Public Health
Background:
- Obesity is a chronic disease with significant health and economic impacts.
- Current obesity treatments are often conservative, delaying effective interventions.
- Other chronic diseases utilize remission-oriented strategies.
Purpose of the Study:
- To propose a remission-oriented paradigm for obesity management.
- To define obesity remission as a multidimensional, sustained state.
- To introduce an induction-remission-maintenance model for obesity.
Main Methods:
- Conceptual framework development.
- Literature review of chronic disease management strategies.
- Defining multidimensional criteria for obesity remission.
Main Results:
- Obesity remission is defined as achieving adiposity targets, resolving complications, restoring function, and improving well-being.
- Remission is conceptualized as a continuum, potentially maintained with pharmacotherapy.
- An induction-remission-maintenance model is proposed for early, effective intervention.
Conclusions:
- A remission-oriented approach offers a structured model for obesity management.
- This paradigm can improve clinical outcomes and reduce healthcare burden.
- Long-term monitoring and disease surveillance are crucial even with effective therapies.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:23Binge Eating Disorders
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...